Nuri Peker։ 1PN and 3PN Embryos May Still Represent a Potential Option
Nuri Peker, IVF Trainer, Medical Doctor, and Reproductive Endocrinologist at Acibadem Healthcare Group, shared a post on LinkedIn about a paper he co-authored with colleagues published in PLOS One.
“Our study shows that blastocyst formation, euploidy, and pregnancy rates from abnormally fertilized 1PN and 3PN embryos are markedly lower than those from normally fertilized embryos.
However, in selected cases where no transferable 2PN blastocysts are available, embryos derived from 1PN and 3PN zygotes may still represent a potential option”
Title: Clinical outcomes of 1PN- and 3PN-derived blastocysts in the absence of transferable 2PN embryos: A retrospective analysis
Authors: Nuri Peker, Ayşen Yücetürk, Esra Tığlı, Özge Karaosmaoğlu, Burak Elmas, İlke Özer Aslan, Bülent Tıraş
You can read the Full Article in PLOS One.
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Oct 23, 2026, 17:06Emad Sedeek: ESHRE Recommendations on Good Practice in the IVF Laboratory 2026 – Part 2
-
Oct 23, 2026, 16:59Nitiz Murdia: Guiding You Through IVF – Your Journey’s Pilot
-
Oct 23, 2026, 16:56Ben Peipert: Come See My Poster Presentation at ASRM 2026
-
Oct 23, 2026, 16:50New RBMO Review Examines Benefits and Risks of Freeze-All IVF Strategies Across Ovarian Response Groups
-
Oct 23, 2026, 16:381 Week and Counting to the Next Campus Course on Male Infertility – ESHRE
-
Oct 23, 2026, 16:34Lynn Mason: Taking Our Research at ASRM Beyond the Conference and Into Patient Care
-
Oct 23, 2026, 16:23Devyanshi Dixit: Why Does Stress Sometimes Amplify Gynecological Pain?
-
Oct 23, 2026, 16:20Indira Fertility Academy Announces “ICSI Revisited” Webinar with Steven Fleming on October 30
-
Oct 23, 2026, 16:15Clara Estela Fernández: My Last Day at Eugin Group